BIRC5 and acute myeloid leukemia: Interestingly, survivin overexpression in MUC1 silenced AML cells led to increased resistance to Ara‐C treatment in AML cells, confirming that MUC1 renders AML more resistant to cytotoxic injury in part via surviving‐mediated mechanism.